Industry: Medical Devices & Consumables
Published Date: 2026-01-08
Pages: 124 Pages
Report ld: 5597987
Request Sample
Customized Report
Bioabsorbable Eluting Coronary Stent System Market Size(US$)

CAGR 2026-2032
4.3%
Market Size,2032
USD 8,376
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Bioabsorbable Eluting Coronary Stent System market was valued at US$ 6255 million in 2025 and is anticipated to reach US$ 8376 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Bioabsorbable Eluting Coronary Stent System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The bioresorbable eluting coronary stent system is a new type of coronary stent, made of degradable materials, which can be gradually absorbed by the human body after completing the tasks of vascular support and drug release, restoring the natural state of the blood vessels and reducing the risks of long-term implants. This stent is coated with a drug coating on the surface of the stent to slowly release drugs to inhibit vascular intimal hyperplasia and reduce the occurrence of restenosis.
The North American market for Bioabsorbable Eluting Coronary Stent System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Bioabsorbable Eluting Coronary Stent System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Bioabsorbable Eluting Coronary Stent System include Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Bioabsorbable Eluting Coronary Stent System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bioabsorbable Eluting Coronary Stent System. The Bioabsorbable Eluting Coronary Stent System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bioabsorbable Eluting Coronary Stent System market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bioabsorbable Eluting Coronary Stent System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Bioabsorbable Eluting Coronary Stent System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Bioabsorbable Eluting Coronary Stent System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Bioabsorbable Eluting Coronary Stent System Market Overview
1.1 Product Definition
1.2 Bioabsorbable Eluting Coronary Stent System by Type
1.2.1 Global Bioabsorbable Eluting Coronary Stent System Market Value by Type: 2025 vs 2032
1.2.2 Rapamycin Eluting Stent
1.2.3 Everolimus Eluting Stent
1.2.4 Others
1.3 Bioabsorbable Eluting Coronary Stent System by Application
1.3.1 Global Bioabsorbable Eluting Coronary Stent System Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global Bioabsorbable Eluting Coronary Stent System Market Size Estimates and Forecasts
1.4.1 Global Bioabsorbable Eluting Coronary Stent System Revenue 2021–2032
1.4.2 Global Bioabsorbable Eluting Coronary Stent System Sales 2021–2032
1.4.3 Global Bioabsorbable Eluting Coronary Stent System Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Bioabsorbable Eluting Coronary Stent System Market Competition by Manufacturers
2.1 Global Bioabsorbable Eluting Coronary Stent System Sales Market Share by Manufacturers (2021–2026)
2.2 Global Bioabsorbable Eluting Coronary Stent System Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Bioabsorbable Eluting Coronary Stent System Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Bioabsorbable Eluting Coronary Stent System, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Bioabsorbable Eluting Coronary Stent System, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Bioabsorbable Eluting Coronary Stent System, Product Types and Applications
2.7 Global Key Manufacturers of Bioabsorbable Eluting Coronary Stent System, Date of Entry into the Industry
2.8 Global Bioabsorbable Eluting Coronary Stent System Market Competitive Situation and Trends
2.8.1 Global Bioabsorbable Eluting Coronary Stent System Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Bioabsorbable Eluting Coronary Stent System Players Market Share by Revenue
2.8.3 Global Bioabsorbable Eluting Coronary Stent System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bioabsorbable Eluting Coronary Stent System Market Scenario by Region
3.1 Global Bioabsorbable Eluting Coronary Stent System Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Bioabsorbable Eluting Coronary Stent System Sales by Region: 2021–2032
3.2.1 Global Bioabsorbable Eluting Coronary Stent System Sales by Region: 2021–2026
3.2.2 Global Bioabsorbable Eluting Coronary Stent System Sales by Region: 2027–2032
3.3 Global Bioabsorbable Eluting Coronary Stent System Revenue by Region: 2021–2032
3.3.1 Global Bioabsorbable Eluting Coronary Stent System Revenue by Region: 2021–2026
3.3.2 Global Bioabsorbable Eluting Coronary Stent System Revenue by Region: 2027–2032
3.4 North America Bioabsorbable Eluting Coronary Stent System Market Facts & Figures by Country
3.4.1 North America Bioabsorbable Eluting Coronary Stent System Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Bioabsorbable Eluting Coronary Stent System Sales by Country (2021–2032)
3.4.3 North America Bioabsorbable Eluting Coronary Stent System Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bioabsorbable Eluting Coronary Stent System Market Facts & Figures by Country
3.5.1 Europe Bioabsorbable Eluting Coronary Stent System Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Bioabsorbable Eluting Coronary Stent System Sales by Country (2021–2032)
3.5.3 Europe Bioabsorbable Eluting Coronary Stent System Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bioabsorbable Eluting Coronary Stent System Market Facts & Figures by Region
3.6.1 Asia Pacific Bioabsorbable Eluting Coronary Stent System Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Bioabsorbable Eluting Coronary Stent System Sales by Region (2021–2032)
3.6.3 Asia Pacific Bioabsorbable Eluting Coronary Stent System Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bioabsorbable Eluting Coronary Stent System Market Facts & Figures by Country
3.7.1 Latin America Bioabsorbable Eluting Coronary Stent System Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Bioabsorbable Eluting Coronary Stent System Sales by Country (2021–2032)
3.7.3 Latin America Bioabsorbable Eluting Coronary Stent System Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bioabsorbable Eluting Coronary Stent System Market Facts & Figures by Country
3.8.1 Middle East and Africa Bioabsorbable Eluting Coronary Stent System Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Bioabsorbable Eluting Coronary Stent System Sales by Country (2021–2032)
3.8.3 Middle East and Africa Bioabsorbable Eluting Coronary Stent System Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bioabsorbable Eluting Coronary Stent System Sales by Type (2021–2032)
4.1.1 Global Bioabsorbable Eluting Coronary Stent System Sales by Type (2021–2026)
4.1.2 Global Bioabsorbable Eluting Coronary Stent System Sales by Type (2027–2032)
4.1.3 Global Bioabsorbable Eluting Coronary Stent System Sales Market Share by Type (2021–2032)
4.2 Global Bioabsorbable Eluting Coronary Stent System Revenue by Type (2021–2032)
4.2.1 Global Bioabsorbable Eluting Coronary Stent System Revenue by Type (2021–2026)
4.2.2 Global Bioabsorbable Eluting Coronary Stent System Revenue by Type (2027–2032)
4.2.3 Global Bioabsorbable Eluting Coronary Stent System Revenue Market Share by Type (2021–2032)
4.3 Global Bioabsorbable Eluting Coronary Stent System Price by Type (2021–2032)
5 Segment by Application
5.1 Global Bioabsorbable Eluting Coronary Stent System Sales by Application (2021–2032)
5.1.1 Global Bioabsorbable Eluting Coronary Stent System Sales by Application (2021–2026)
5.1.2 Global Bioabsorbable Eluting Coronary Stent System Sales by Application (2027–2032)
5.1.3 Global Bioabsorbable Eluting Coronary Stent System Sales Market Share by Application (2021–2032)
5.2 Global Bioabsorbable Eluting Coronary Stent System Revenue by Application (2021–2032)
5.2.1 Global Bioabsorbable Eluting Coronary Stent System Revenue by Application (2021–2026)
5.2.2 Global Bioabsorbable Eluting Coronary Stent System Revenue by Application (2027–2032)
5.2.3 Global Bioabsorbable Eluting Coronary Stent System Revenue Market Share by Application (2021–2032)
5.3 Global Bioabsorbable Eluting Coronary Stent System Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Medtronic Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abbott Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 B.Braun
6.4.1 B.Braun Company Information
6.4.2 B.Braun Description and Business Overview
6.4.3 B.Braun Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 B.Braun Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.4.5 B.Braun Recent Developments/Updates
6.5 BD
6.5.1 BD Company Information
6.5.2 BD Description and Business Overview
6.5.3 BD Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BD Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.5.5 BD Recent Developments/Updates
6.6 Biotronik AG
6.6.1 Biotronik AG Company Information
6.6.2 Biotronik AG Description and Business Overview
6.6.3 Biotronik AG Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Biotronik AG Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.6.5 Biotronik AG Recent Developments/Updates
6.7 Stentys SA
6.7.1 Stentys SA Company Information
6.7.2 Stentys SA Description and Business Overview
6.7.3 Stentys SA Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Stentys SA Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.7.5 Stentys SA Recent Developments/Updates
6.8 Sino Medical
6.8.1 Sino Medical Company Information
6.8.2 Sino Medical Description and Business Overview
6.8.3 Sino Medical Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sino Medical Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.8.5 Sino Medical Recent Developments/Updates
6.9 Beijing ESSEN Technology
6.9.1 Beijing ESSEN Technology Company Information
6.9.2 Beijing ESSEN Technology Description and Business Overview
6.9.3 Beijing ESSEN Technology Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Beijing ESSEN Technology Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.9.5 Beijing ESSEN Technology Recent Developments/Updates
6.10 Beijing Advanced Medical Technologies
6.10.1 Beijing Advanced Medical Technologies Company Information
6.10.2 Beijing Advanced Medical Technologies Description and Business Overview
6.10.3 Beijing Advanced Medical Technologies Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Beijing Advanced Medical Technologies Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.10.5 Beijing Advanced Medical Technologies Recent Developments/Updates
6.11 LifeTech Scientific Corporation
6.11.1 LifeTech Scientific Corporation Company Information
6.11.2 LifeTech Scientific Corporation Description and Business Overview
6.11.3 LifeTech Scientific Corporation Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 LifeTech Scientific Corporation Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.11.5 LifeTech Scientific Corporation Recent Developments/Updates
6.12 MicroPort Scientific Corporation
6.12.1 MicroPort Scientific Corporation Company Information
6.12.2 MicroPort Scientific Corporation Description and Business Overview
6.12.3 MicroPort Scientific Corporation Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 MicroPort Scientific Corporation Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.12.5 MicroPort Scientific Corporation Recent Developments/Updates
6.13 Yilson Medical Technology
6.13.1 Yilson Medical Technology Company Information
6.13.2 Yilson Medical Technology Description and Business Overview
6.13.3 Yilson Medical Technology Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Yilson Medical Technology Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.13.5 Yilson Medical Technology Recent Developments/Updates
6.14 Lepu Medical Technology
6.14.1 Lepu Medical Technology Company Information
6.14.2 Lepu Medical Technology Description and Business Overview
6.14.3 Lepu Medical Technology Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Lepu Medical Technology Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.14.5 Lepu Medical Technology Recent Developments/Updates
6.15 Shandong Hua'an Biotechnology
6.15.1 Shandong Hua'an Biotechnology Company Information
6.15.2 Shandong Hua'an Biotechnology Description and Business Overview
6.15.3 Shandong Hua'an Biotechnology Bioabsorbable Eluting Coronary Stent System Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Shandong Hua'an Biotechnology Bioabsorbable Eluting Coronary Stent System Product Portfolio
6.15.5 Shandong Hua'an Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bioabsorbable Eluting Coronary Stent System Industry Chain Analysis
7.2 Bioabsorbable Eluting Coronary Stent System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bioabsorbable Eluting Coronary Stent System Production Mode & Process Analysis
7.4 Bioabsorbable Eluting Coronary Stent System Sales and Marketing
7.4.1 Bioabsorbable Eluting Coronary Stent System Sales Channels
7.4.2 Bioabsorbable Eluting Coronary Stent System Distributors
7.5 Bioabsorbable Eluting Coronary Stent System Customer Analysis
8 Bioabsorbable Eluting Coronary Stent System Market Dynamics
8.1 Bioabsorbable Eluting Coronary Stent System Industry Trends
8.2 Bioabsorbable Eluting Coronary Stent System Market Drivers
8.3 Bioabsorbable Eluting Coronary Stent System Market Challenges
8.4 Bioabsorbable Eluting Coronary Stent System Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Bioabsorbable Eluting Coronary Stent System market is projected to grow from US$ 6255 million in 2025 to US$ 8376 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 170
USD 4900.00
(Single User License)
The global Bioabsorbable Eluting Coronary Stent System market size was US$ 6255 million in 2025 and is forecast to reach a readjusted size of US$ 8376 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 95
USD 4250.00
(Single User License)
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 6255 million in 2025 and is projected to reach US$ 8376 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 118
USD 3950.00
(Single User License)
The global Bioabsorbable Eluting Coronary Stent System market size was US$ 6021 million in 2024 and is forecast to a readjusted size of US$ 8062 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 94
USD 4250.00
(Single User License)
The global Bioabsorbable Eluting Coronary Stent System market is projected to grow from US$ 6021 million in 2024 to US$ 8062 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 162
USD 4900.00
(Single User License)
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 6021 million in 2024 and is forecast to a readjusted size of US$ 8062 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 120
USD 3950.00
(Single User License)
The global market for Bioabsorbable Eluting Coronary Stent System was valued at US$ 6021 million in the year 2024 and is projected to reach a revised size of US$ 8062 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-03-10
Pages: 93
USD 2900.00
(Single User License)
The bioresorbable eluting coronary stent system is a new type of coronary stent, made of degradable materials, which can be gradually absorbed by the human body after completing the tasks of vascular support and drug release, restoring the natural state of the blood vessels and reducing the risks of long-term implants. This stent is coated with a drug coating on the surface of the stent to slowly release drugs to inhibit vascular intimal hyperplasia and reduce the occurrence of restenosis.
Published Date: 2024-12-14
Pages: 136
USD 4350.00
(Single User License)
Valued at US$ 6021 million in 2024, the global Bioabsorbable Eluting Coronary Stent System market is forecast to reach US$ 7761 million by 2030, at a CAGR of 4.3% during the forecast period.
Published Date: 2024-11-22
Pages: 154
USD 4900.00
(Single User License)
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 5769 million in 2023 and is forecast to a readjusted size of US$ 7761 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
Published Date: 2024-11-22
Pages: 118
USD 3950.00
(Single User License)
The global Bioabsorbable Eluting Coronary Stent System market is projected to grow from US$ 6255 million in 2025 to US$ 8376 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 170
The global Bioabsorbable Eluting Coronary Stent System market size was US$ 6255 million in 2025 and is forecast to reach a readjusted size of US$ 8376 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 95
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 6255 million in 2025 and is projected to reach US$ 8376 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 118
The global Bioabsorbable Eluting Coronary Stent System market size was US$ 6021 million in 2024 and is forecast to a readjusted size of US$ 8062 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 94
The global Bioabsorbable Eluting Coronary Stent System market is projected to grow from US$ 6021 million in 2024 to US$ 8062 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 162
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 6021 million in 2024 and is forecast to a readjusted size of US$ 8062 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 120
The global market for Bioabsorbable Eluting Coronary Stent System was valued at US$ 6021 million in the year 2024 and is projected to reach a revised size of US$ 8062 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-03-10
Pages: 93
The bioresorbable eluting coronary stent system is a new type of coronary stent, made of degradable materials, which can be gradually absorbed by the human body after completing the tasks of vascular support and drug release, restoring the natural state of the blood vessels and reducing the risks of long-term implants. This stent is coated with a drug coating on the surface of the stent to slowly release drugs to inhibit vascular intimal hyperplasia and reduce the occurrence of restenosis.
Published: 2024-12-14
Pages: 136
Valued at US$ 6021 million in 2024, the global Bioabsorbable Eluting Coronary Stent System market is forecast to reach US$ 7761 million by 2030, at a CAGR of 4.3% during the forecast period.
Published: 2024-11-22
Pages: 154
The global market for Bioabsorbable Eluting Coronary Stent System was estimated to be worth US$ 5769 million in 2023 and is forecast to a readjusted size of US$ 7761 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
Published: 2024-11-22
Pages: 118
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now